160 related articles for article (PubMed ID: 2068687)
21. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis].
Keller L; Fischer J; Farádi A
Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692
[No Abstract] [Full Text] [Related]
22. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
Tedeschi-Reiner E; Reiner Z; Sonicki Z
Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
[TBL] [Abstract][Full Text] [Related]
23. [The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
Zhukova IM; Iurenev AP; Pomerantsev EV; Martynov AA; Shabalkin BV; Titov VN; Shimbaeva NA; Kotkina AA; Bochkova EI; Lediashova GA
Ter Arkh; 1990; 62(8):130-3. PubMed ID: 2274859
[TBL] [Abstract][Full Text] [Related]
24. [Action of purified phospholipids on the serum lipid pattern].
Tralli G
Clin Ter; 1977 Mar; 80(6):545-51. PubMed ID: 862355
[No Abstract] [Full Text] [Related]
25. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis].
Eninia GI; Smeltere ES; Godlevska MA; Logina IP
Klin Med (Mosk); 1985 Sep; 63(9):45-8. PubMed ID: 4068626
[No Abstract] [Full Text] [Related]
26. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
27. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
Alaupovic P; Blankenhorn DH
Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
[TBL] [Abstract][Full Text] [Related]
28. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H
Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
[TBL] [Abstract][Full Text] [Related]
29. The European (EAS) and the American (NCEP) cholesterol guidelines: are they still adequate?
Sztern M; Dujovne CA
Postgrad Med J; 1989; 65 Suppl 1():S2-5. PubMed ID: 2622810
[No Abstract] [Full Text] [Related]
30. [Physical exertion tolerance in patients with ischemic heart disease associated with cerebral arteriosclerosis].
Dzizinskiĭ AA; Cherniak BA
Ter Arkh; 1984; 56(12):28-32. PubMed ID: 6523408
[TBL] [Abstract][Full Text] [Related]
31. [Gemfibrozil in the treatment of lipid metabolism disorders].
Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
[TBL] [Abstract][Full Text] [Related]
32. Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure.
Schwabedal PE; Brügging-Schmitz G; Oestreich W; Szathmary SC
J Hypertens Suppl; 1989 Dec; 7(6):S280-1. PubMed ID: 2632726
[No Abstract] [Full Text] [Related]
33. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
Danilova IN; Neretin VIa; Nesterova LA
Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
[No Abstract] [Full Text] [Related]
34. The fatty acid composition of serum total lipids and lipid fractions in coronary heart disease and cerebral atherosclerosis.
Abdel Hay A; Kramer M; Keller L; Retsagi G
J Egypt Med Assoc; 1970; 53(5):309-20. PubMed ID: 5506287
[No Abstract] [Full Text] [Related]
35. [The clinico-biochemical blood indices of patients with cerebral atherosclerosis and a history of stroke].
Chernenko NI; Vishnevskaia TM; Godyna SV; Leliukhina EV; Shutova TM; Evenko AN
Vrach Delo; 1990 Nov; (11):55-7. PubMed ID: 2098986
[No Abstract] [Full Text] [Related]
36. Plasma lipids and coronary atherosclerosis in Japanese men.
Nakaya Y; Hiasa Y; Morimoto S
Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
[TBL] [Abstract][Full Text] [Related]
37. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
Kaliman J; Widhalm K; Strobl W
Artery; 1980; 8(6):547-52. PubMed ID: 7259533
[TBL] [Abstract][Full Text] [Related]
38. [The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
Nikitin AV; Chesnokova IV; Sysoeva LI
Vrach Delo; 1990 Nov; (11):17-8. PubMed ID: 2098971
[TBL] [Abstract][Full Text] [Related]
39. [Lipids and lipoproteins in atherosclerotic arteriopathy of the legs. Unusual study of very low density lipoproteins].
Duchassaing D; Dezellus P; Guenée B; Tenenhaus D; Jarnet J; Paris M; Housset E; Leclerc M
Pathol Biol (Paris); 1985 Nov; 33(9):881-5. PubMed ID: 3909080
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of atherosclerosis.
Segrest JP; Anantharamaiah GM
Curr Opin Cardiol; 1994 Jul; 9(4):404-10. PubMed ID: 7919584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
